Jeffrey H. Newcorn

31.0k total citations · 7 hit papers
298 papers, 17.2k citations indexed

About

Jeffrey H. Newcorn is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Jeffrey H. Newcorn has authored 298 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 252 papers in Psychiatry and Mental health, 116 papers in Cognitive Neuroscience and 108 papers in Clinical Psychology. Recurrent topics in Jeffrey H. Newcorn's work include Attention Deficit Hyperactivity Disorder (248 papers), Child and Adolescent Psychosocial and Emotional Development (93 papers) and Neural and Behavioral Psychology Studies (68 papers). Jeffrey H. Newcorn is often cited by papers focused on Attention Deficit Hyperactivity Disorder (248 papers), Child and Adolescent Psychosocial and Emotional Development (93 papers) and Neural and Behavioral Psychology Studies (68 papers). Jeffrey H. Newcorn collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey H. Newcorn's co-authors include Jeffrey M. Halperin, Susan E. Sprich, J Biederman, James M. Swanson, Peter S. Jensen, Kurt P. Schulz, Laurence L. Greenhill, Lily Hechtman, Stephen P. Hinshaw and L. Eugene Arnold and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Neuroscience.

In The Last Decade

Jeffrey H. Newcorn

288 papers receiving 16.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

1991 1.3k citations Jeffrey H. Newcorn et al. profile →
The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

2009 834 citations Laurence L. Greenhill, Jeffrey H. Newcorn et al. Journal of the American Academy of Child & Adolescent Psychiatry profile →
DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents

1994 730 citations Laurence L. Greenhill, Jeffrey H. Newcorn et al. profile →
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups

2001 682 citations Jeffrey H. Newcorn, Laurence L. Greenhill et al. Journal of the American Academy of Child & Adolescent Psychiatry profile →
Practitioner Review: Emotional dysregulation in attention‐deficit/hyperactivity disorder – implications for clinical recognition and intervention

2018 239 citations Stephen V. Faraone, Ann Childress et al. Journal of Child Psychology and Psychiatry profile →
Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD

2021 175 citations Margaret H. Sibley, Jeffrey H. Newcorn et al. profile →
Attention-deficit/hyperactivity disorder

2024 99 citations Stephen V. Faraone, Mark A. Bellgrove et al. Nature Reviews Disease Primers profile →

Peers

Countries citing papers authored by Jeffrey H. Newcorn

Since Specialization

Citations

This map shows the geographic impact of Jeffrey H. Newcorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey H. Newcorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey H. Newcorn more than expected).

Fields of papers citing papers by Jeffrey H. Newcorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey H. Newcorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey H. Newcorn. The network helps show where Jeffrey H. Newcorn may publish in the future.

Co-authorship network of co-authors of Jeffrey H. Newcorn

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey H. Newcorn. A scholar is included among the top collaborators of Jeffrey H. Newcorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey H. Newcorn. Jeffrey H. Newcorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The synergy of methylphenidate- and reconsolidation-based extinction normalizes ventromedial prefrontal function in drug addiction 2025 ·Proceedings of the National Academy of Sciences ·Ahmet O. Ceceli, (unknown), (unknown), Natalie McClain, J. A. Muir Gray, (unknown), Jeffrey H. Newcorn, Daniela Schiller, Nelly Alia‐Klein, Rita Z. Goldstein	0
2	Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies 2025 ·Clinical Drug Investigation ·Matia B. Solomon, (unknown), Jeffrey H. Newcorn, Vladimir Maletic, Jonathan Rubin, Trevor W. Robbins	0
3	Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals 2025 ·The Lancet Psychiatry ·Miguel Garcia‐Argibay, Zheng Chang, Isabell Brikell, Ralf Kuja‐Halkola, Brian M. D’Onofrio, Paul Lichtenstein, Jeffrey H. Newcorn, Stephen V. Faraone, Henrik Larsson, Samuele Cortese	5
4	Author Correction: Attention-deficit/hyperactivity disorder 2024 ·Nature Reviews Disease Primers ·Stephen V. Faraone, Mark A. Bellgrove, Isabell Brikell, Samuele Cortese, Catharina A. Hartman, Chris Hollis, Jeffrey H. Newcorn, Alexandra Philipsen, Guilherme V. Polanczyk, Katya Rubia, Margaret H. Sibley, Jan K. Buitelaar	1
5	Attention-deficit/hyperactivity disorder breakdown → 2024 ·Nature Reviews Disease Primers ·Stephen V. Faraone, Mark A. Bellgrove, Isabell Brikell, Samuele Cortese, Catharina A. Hartman, Chris Hollis, Jeffrey H. Newcorn, Alexandra Philipsen, Guilherme V. Polanczyk, Katya Rubia, Margaret H. Sibley, Jan K. Buitelaar	99
6	Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study 2024 ·Journal of Child and Adolescent Psychopharmacology ·Jeffrey R. Bishop, Chuan Zhou, Andrea Gaedigk, (unknown), Rick A. Kittles, Edwin H. Cook, Jeffrey H. Newcorn, Mark A. Stein	2
7	Common and distinct fronto-striatal volumetric changes in heroin and cocaine use disorders 2022 ·Brain ·Ahmet O. Ceceli, Yuefeng Huang, Greg Kronberg, Pias Malaker, (unknown), (unknown), Pierre‐Olivier Gaudreault, Natalie McClain, (unknown), (unknown), Jeffrey H. Newcorn, (unknown), Nelly Alia‐Klein, Rita Z. Goldstein	17
8	Annual Research Review: Perspectives on progress in ADHD science – from characterization to cause 2022 ·Journal of Child Psychology and Psychiatry ·Edmund Sonuga‐Barke, Stephen Becker, Sven Bölte, F. Xavier Castellanos, Barbara Franke, Jeffrey H. Newcorn, Joel T. Nigg, Luís Augusto Rohde, Emily Simonoff	70
9	Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study 2019 ·Journal of Child and Adolescent Psychopharmacology ·Iliyan Ivanov, Kurt P. Schulz, Xiaobo Li, Jeffrey H. Newcorn	6
10	Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder 2017 ·Journal of Child and Adolescent Psychopharmacology ·Steven R. Pliszka, Timothy E. Wilens, (unknown), Valerie Arnold, (unknown), Andrew J. Cutler, Frank A. López, (unknown), Floyd R. Sallee, Bev Incledon, Jeffrey H. Newcorn, (unknown)	26
11	A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 2016 ·Journal of Child and Adolescent Psychopharmacology ·Ann Childress, Jeffrey H. Newcorn, Jeffrey G. Stark, (unknown), (unknown), Carolyn R. Sikes	16
12	College Students, Prescription Stimulant, and Other Substance Abuse 2015 ·(unknown), Jeffrey H. Newcorn	1
13	Single-Dose Pharmacokinetics of Methylphenidate Extended-Release Multiple Layer Beads Administered as Intact Capsule or Sprinkles Versus Methylphenidate Immediate-Release Tablets (Ritalin ^® ) in Healthy Adult Volunteers 2014 ·Journal of Child and Adolescent Psychopharmacology ·Akwete Adjei, Nathan S. Teuscher, Robert Kupper, Weiwei Chang, Laurence L. Greenhill, Jeffrey H. Newcorn, Daniel F. Connor, Sharon B. Wigal	24
14	Efficacy of Guanfacine Extended Release Assessed During the Morning, Afternoon, and Evening Using a Modified Conners' Parent Rating Scale–Revised: Short Form 2014 ·Journal of Child and Adolescent Psychopharmacology ·Joel Young, Thomas A. Rugino, Ryan Dammerman, A. G. Lyne, Jeffrey H. Newcorn	13
15	Global Methylation in the Placenta and Umbilical Cord Blood From Pregnancies With Maternal Gestational Diabetes, Preeclampsia, and Obesity 2013 ·Reproductive Sciences ·Yoko Nomura, Luca Lambertini, Alexander Rialdi, Men‐Jean Lee, (unknown), (unknown), (unknown), Nancy Huynh, Jackie Finik, (unknown), (unknown), Jenny Ly, Joanne Stone, Holly Loudon, Gary S. Eglinton, Yasmin L. Hurd, Jeffrey H. Newcorn, Jia Chen	124
16	A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples 2012 ·Biomedical Chromatography ·(unknown), Bryan J. Brinda, John S. Markowitz, Jeffrey H. Newcorn, Hao‐Jie Zhu	9
17	Dose–Response Characteristics in Adolescents with Attention-Deficit/Hyperactivity Disorder Treated with OROS ^® Methylphenidate in a 4-Week, Open-Label, Dose-Titration Study 2010 ·Journal of Child and Adolescent Psychopharmacology ·Jeffrey H. Newcorn, Mark A. Stein, Kimberly Cooper	26
18	Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of Child and Adolescent Psychopharmacology ·Mary V. Solanto, Jeffrey H. Newcorn, (unknown), (unknown), Iliyan Ivanov, (unknown)	60
19	Characteristics of Placebo Responders in Pediatric Clinical Trials of Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Jeffrey H. Newcorn, Virginia K. Sutton, Shuyu Zhang, Timothy E. Wilens, Christopher J. Kratochvil, Graham J. Emslie, Deborah N. D’Souza, Leslie M. Schuh, Albert J. Allen	34
20	Parent and Teacher Ratings of Attention-Deficit Hyperactivity Disorder Symptoms 1994 ·Journal of Developmental & Behavioral Pediatrics ·Jeffrey H. Newcorn, Jeffrey M. Halperin, Susan T. Schwartz, (unknown), Lorraine E. Wolf, James Schmeidler, Vanshdeep Sharma	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact